SIAS Research starts C&O Pharmaceutical Technology (E92.SG) with an “increase exposure” call and 45.6 cents target price, reported Dow Jones Newswires.
C&O Pharm initiated at ‘increase exposure’ by SIAS
written by Editor on March 19th, 2010 |
No Comments
Font size:
